http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9514714

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't|Review
endingPage 6908
issn 1078-0432
1557-3265
issueIdentifier 23
pageRange 6899-6908
publicationName Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage 6899
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_2f1f5a3920787349e896f76286119f3a
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_259ae0443f2d892d0931963c85da723b
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b764b3554ad23ec90d3cff07f3e13505
bibliographicCitation Parseghian CM, Napolitano S, Loree JM, Kopetz S. Mechanisms of Innate and Acquired Resistance to Anti-EGFR Therapy: A Review of Current Knowledge with a Focus on Rechallenge Therapies. Clin Cancer Res. 2019 Dec 01;25(23):6899–908. PMID: 31263029; PMCID: PMC6891150.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_191abe237df756edfb5f2bec40ac4508
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2047-097X
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9b6db2fed7a8bf30b4c2ee4ecb4e2693
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8189-2132
date 2019-12-01^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC6891150
https://doi.org/10.1158/1078-0432.ccr-19-0823
https://pubmed.ncbi.nlm.nih.gov/31263029
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794
https://portal.issn.org/resource/ISSN/1557-3265
https://portal.issn.org/resource/ISSN/1078-0432
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Mechanisms of Innate and Acquired Resistance to Anti-EGFR Therapy: A Review of Current Knowledge with a Focus on Rechallenge Therapies
discusses http://id.nlm.nih.gov/mesh/M0022149
http://id.nlm.nih.gov/mesh/M0593322
http://id.nlm.nih.gov/mesh/M0500817
http://id.nlm.nih.gov/mesh/M0457532
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D014408Q000235
http://id.nlm.nih.gov/mesh/D058990
http://id.nlm.nih.gov/mesh/D047428Q000494
http://id.nlm.nih.gov/mesh/D019008Q000235
http://id.nlm.nih.gov/mesh/D009369Q000188
http://id.nlm.nih.gov/mesh/D009369Q000235
hasSubjectTerm http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D009154
http://id.nlm.nih.gov/mesh/D066246Q000037
http://id.nlm.nih.gov/mesh/D066246Q000235
http://id.nlm.nih.gov/mesh/D009369Q000473
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_bcd6f21312d21a5cf3f0a82f59d9ac97
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9672
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c7be83279551b50c0e81dc2dbfe3c5d8
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6569
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e8ad08f759b2798c1b5dca78861cc6ce

Showing number of triples: 1 to 52 of 52.